Herbaux C, Bachy E, Bouabdallah R, Guidez S, et al. Atezolizumab, obinutuzumab and venetoclax for the treatment of patients with relapsed/refractory B non-Hodgkin lymphoma: Final analysis of a phase II trial from the LYSA group. Br J Haematol 2025 Apr 26. doi: 10.1111/bjh.20109.
PMID: 40285420